首页> 外文期刊>Journal of peptide science: An official publication of the European Peptide Society >Structural studies and model membrane interactions of two peptides derived from bovine lactoferricin
【24h】

Structural studies and model membrane interactions of two peptides derived from bovine lactoferricin

机译:牛乳铁蛋白两种肽的结构研究和模型膜相互作用

获取原文
获取原文并翻译 | 示例
       

摘要

The powerful antimicrobial properties of bovine lactoferricin (LfcinB) make it attractive for the development of new antimicrobial agents. An 11-residue linear peptide portion of LfcinB has been reported to have similar antimicrobial activity to lactoferricin itself, but with lower hemolytic activity. The membrane-binding and membrane-perturbing properties of this peptide were studied together with an amidated synthetic version with an added disulfide bond, which was designed to confer increased stability and possibly activity. The antimicrobial and cytotoxic properties of the peptides were measured against Staphylococcus aureus and Escherichia coli and by hemolysis assays. The peptides were also tested in an anti-cancer assay against neuroblastoma cell lines. Vesicle disruption caused by these LfcinB derivatives was studied using the fluorescent reporter molecule calcein. The extent of burial of the two Trp residues in membrane mimetic environments were quantitated by fluorescence. Finally, the solution NMR structures of the peptides bound to SDS micelles were determined to provide insight into their membrane bound state. The cyclic peptide was found to have greater antimicrobial potency than its linear counterpart. Consistent with this property, the two Trp residues of the modified peptide were suggested to be embedded deeper into the membrane. Although both peptides adopt an amphipathic structure without any regular a-helical or beta-sheet conformation, the 3D-structures revealed a clearer partitioning of the cationic and hydrophobic faces for the cyclic peptide. Copyright (c) 2004 European Peptide Society and John Wiley & Sons, Ltd.
机译:牛乳铁蛋白(LfcinB)的强大抗菌特性使其对新型抗菌剂的开发具有吸引力。据报道,LfcinB的11个残基的线性肽部分具有与乳铁蛋白本身相似的抗菌活性,但溶血活性较低。研究了该肽的膜结合和膜扰动特性,以及带有添加的二硫键的酰胺化合成肽,后者旨在赋予其更高的稳定性和可能的​​活性。通过溶血测定法测定了该肽对金黄色葡萄球菌和大肠杆菌的抗微生物和细胞毒性特性。还在抗神经母细胞瘤细胞系的抗癌试验中测试了这些肽。使用荧光报告分子钙黄绿素研究了由这些LfcinB衍生物引起的囊泡破坏。通过荧光定量膜模拟环境中两个Trp残基的掩埋程度。最后,确定与SDS胶束结合的肽的溶液NMR结构,以提供对它们的膜结合状态的了解。发现环状肽比其线性对应物具有更大的抗菌效力。与该性质一致,修饰肽的两个Trp残基被建议更深地嵌入膜中。尽管两种肽均采用两亲性结构,而没有任何规则的α-螺旋或β-折叠构象,但3D结构揭示了环状肽的阳离子和疏水表面更清晰的分配。版权所有(c)2004欧洲肽协会和John Wiley&Sons,Ltd.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号